Related references
Note: Only part of the references are listed.Targeting chemokine receptors in HIV: A status report
Shawn E. Kuhmann et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Baseline Resistance of Primary Human Immunodeficiency Virus Type 1 Strains to the CXCR4 Inhibitor AMD3100
Jessamina E. Harrison et al.
JOURNAL OF VIROLOGY (2008)
In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject
Athe M. N. Tsibris et al.
JOURNAL OF VIROLOGY (2008)
Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein
Wei Huang et al.
JOURNAL OF VIROLOGY (2008)
An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence
Brian M. Taylor et al.
JOURNAL OF VIROLOGY (2008)
Mapping resistance to the CCR5 co-receptor antagonist vicriviroc using heterologous chimeric HIV-1 envelope genes reveals key determinants in the C2-V5 domain of gp120
Robert A. Ogert et al.
VIROLOGY (2008)
Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors
Pavel Pugach et al.
VIROLOGY (2008)
Enhancing exposure of HIV-1 neutralization epitopes through mutations in gp41
Catherine A. Blish et al.
PLOS MEDICINE (2008)
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody
Per Johan Klasse
VIROLOGY (2007)
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists
George Lin et al.
JOURNAL OF VIROLOGY (2007)
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies
Meg M. Laakso et al.
PLOS PATHOGENS (2007)
Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligands
Thomas J. Ketas et al.
VIROLOGY (2007)
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a fitness loss
Cleo G. Anastassopoulou et al.
PLOS PATHOGENS (2007)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652
Masanori Baba et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Emergence of CXCR4-Using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-Infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir
M Westby et al.
JOURNAL OF VIROLOGY (2006)
Generation and properties of a human immunodeficiency virus type I isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D)
AJ Marozsan et al.
VIROLOGY (2005)
V3: HIV's switch-hitter
O Hartley et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2005)
Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor
SE Kuhmann et al.
JOURNAL OF VIROLOGY (2004)
The CCR5 and CXCR4 coreceptors - Central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection
JP Moore et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
PF Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Ligand-selective receptor conformations revisited: the promise and the problem
T Kenakin
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
A Trkola et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)